[Progress of the study on the relationship between MxA and interferon therapy of viral hepatitis].
Du
Te
T
National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China.
Liu
Ying
Y
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D019204:GTP-Binding Proteins / Q000627:therapeutic use*; D006525:Hepatitis, Viral, Human / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D064547:Myxovirus Resistance Proteins; D011092:Polyethylene Glycols; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; C579071:MX1 protein, human; D064547:Myxovirus Resistance Proteins; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D007371:Interferon-gamma; D007372:Interferons; D019204:GTP-Binding Proteins; C417083:peginterferon alfa-2b